Use of penicillin in the treatment of carriers of beta-hemolytic streptococci among patients with rheumatic fever
| Autor: | Jessamine R. Goerner, Benedict F. Massell, T. Duckett Jones, Mary Meyeserian |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
education.field_of_study
Isolation (health care) medicine.drug_class business.industry Antibiotics Population Respiratory infection Streptococcus General Medicine Penicillins Haemolysis medicine.disease Penicillin Pharmacotherapy Streptococcal Infections Immunology medicine Rheumatic fever Humans Rheumatic Fever education business medicine.drug |
| Zdroj: | The New England journal of medicine. 237(16) |
| ISSN: | 0028-4793 |
| Popis: | THE danger of hemolytic streptococcus respiratory infection to persons who are susceptible to rheumatic fever is well recognized. Since with present knowledge there are inherent difficulties in evaluating the innocuousness of a given strain, every carrier of beta-hemolytic streptococci must be considered a potential menace to a population of rheumatic-fever patients. Prolonged isolation of such carriers is inadvisable from the psychologic standpoint and is usually impracticable. Hence, means of abolishing the carrier state are desirable. During the administration of sulfonamides to carriers the throat cultures become negative for hemolytic streptococci in some cases, whereas in others the cultures, although remaining . . . |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|